相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles
Kevin Letchford et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Self-assembled honokiol-loaded micelles based on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymer
XiaWei Wei et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Etoposide loaded PLGA and PCL nanoparticles II: Biodistribution and pharmacokinetics after radiolabeling with Tc-99m
Movva Snehalatha et al.
DRUG DELIVERY (2008)
Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors
Ommoleila Molavi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Stability issues of polymeric micelles
You Han Bae et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats
May P. Xiong et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: Formulation, characterization, technetium-99m labeling and biodistribution studies
Kamal Krishna Halder et al.
JOURNAL OF DRUG TARGETING (2008)
Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin
Awesh Kumar Yadav et al.
JOURNAL OF DRUG TARGETING (2008)
Pharmaceutics, preformulation and drug delivery
Kevin Letchford et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin
Jaime A. Yanez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
Keun Seok Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: Pharmacokinetic disposition, tolerability, and cytotoxicity
M. Laird Forrest et al.
PHARMACEUTICAL RESEARCH (2008)
Degradation behaviors of star-shaped poly(ethylene glycol)-poly (ε-caprolactone) nanoparticles in aqueous solution
Chunhua Shen et al.
POLYMER DEGRADATION AND STABILITY (2007)
Doxorubicin and β-lapachone release and interaction with micellar core materials:: Experiment and modeling
Damon Sutton et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2007)
Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity
Jason Zastre et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells
Yong Hu et al.
JOURNAL OF CONTROLLED RELEASE (2007)
In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration
Jubo Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles:: Preparation and in vitro evaluation
Anshu Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: The effect of solvent composition on micellar properties and drug loading
Hamidfeza Montazeri Aliabadi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions:: A fluorogenic-based approach
R Savic et al.
LANGMUIR (2006)
Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin
Y Sadzuka et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Synthesis and physicochemical characterization of Amphiphilic block copolymer self-aggregates formed by poly(ethylene glycol)-block-poly(ε-caprolactone)
C Choi et al.
JOURNAL OF APPLIED POLYMER SCIENCE (2006)
In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(ε-caprolactone) micelles
ML Forrest et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Comparison of two pegylated copolymeric micelles and their potential as drug carriers
WJ Lin et al.
DRUG DELIVERY (2005)
Stealth MePEG-PCL micelles:: effects of polymer composition on micelle physicochemical characteristics, in vitro drug release, in vivo pharmacokinetics in rats and biodistribution in S180 tumor bearing mice
B Shi et al.
COLLOID AND POLYMER SCIENCE (2005)
Micelles of methoxy poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization and controlled delivery of Cyclosporine A
HM Aliabadi et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent
JB Liu et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Preparation of methoxy poly(ethyleneglycol)-block-poly(caprolactone) via activated monomer mechanism and examination of micellar characterization
MS Kim et al.
POLYMER BULLETIN (2005)
Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice
LY Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2004)
About the methods of preparation of poly(ethylene oxide)-b-poly(ε-caprolactone) nanoparticles in water analysis by dynamic light scattering
P Vangeyte et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2004)
Preparation of poly(ethylene glycol)-block-poly(caprolactone) copolymers and their applications as thermo-sensitive materials
MS Kim et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2004)
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Y Matsumura et al.
BRITISH JOURNAL OF CANCER (2004)
Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles
K Avgoustakis et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(ε-caprolactone)-poly(ethylene oxide)-poly(ε-caprolactone) amphiphilic triblock copolymer micelles
HX Ge et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome
Y Sadzuka et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Biodegradable polymeric nanoparticles as drug delivery devices
KS Soppimath et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: Production, colloidal properties and biological performance
S Stolnik et al.
JOURNAL OF DRUG TARGETING (2001)
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG):: influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption
R Gref et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2000)
分享论文
